hotspot -WSS

hotspot

author：comprehensive 2025-09-30 18:53:46 - browse：5

1:56Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Target has recalled another 2.2 million of its Threshold candles due to reports of candle jars breaking or cracking during use.

In May, the United States Consumer Product Safety Commission announced the recall of nearly 5 million Target Threshold candle products after the retailer received 137 reports of it breaking or cracking during use.

Now, the Minnesota-based retailer has recalled another 2.2 million candles, the CPC announced Thursday.

"Target received 19 reports of the candle jar breaking or cracking during use, resulting in one minor injury," the agency stated.

MORE: General Motors recalls over 600K cars due to car seat safety issue

Six injuries were reported in the previous recall, including lacerations and severe burns, according to the CPSC.

"This recall involves certain Threshold Glass Jar 5.5 ounce 1-Wick, 14 ounce 3-Wick and 20 ounce 3-Wick Candles in multiple scents," the CPSC stated. "The recalled item numbers are printed on the bottom of the glass jars."

PHOTO: Threshold Glass Jar Candles sold exclusively by Target. — Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Click here for a full list of the recalled product details and item numbers.

The CPSC urged consumers to stop using the recalled candles immediately and return them to Target for a refund. Customers can also contact Target for a prepaid return label to send them back by mail.

The candles, which were manufactured in Vietnam, were sold at Target stores nationwide as well as online from August 2019 through March 2023 for between $3 and $20.

An earlier version of this story was originally published May 19, 2023.

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Congressmen charge Covid hearing ‘could have been an email’

WSS

FDA drug safety: Singulair case shows systemic surveillance flaws

Commercial surrogacy can be ethical, despite pope’s claims

Republican states more likely to report Covid vaccine side effects

Republican states more likely to report Covid vaccine side effects

Overprescribed: High cost isn't America's only drug problem

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

knowledge

hotspot

MORE: General Motors recalls over 600K cars due to car seat safety issue

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Biden administration opens offers in Medicare drug price negotiations

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Sports medicine is finally prioritizing gender equality

Do digital therapeutics have a future in medicine?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Apple Vision Pro: A first look at health apps on the new VR headset

How one medical school became remarkably diverse

Vertex non

entertainment

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Hundreds died while taking an arthritis drug, but nobody alerted patients

U.K. decision on ALS drug has neurologists, advocates up in arms

Medicare Advantage 2025 payments will dip, Biden administration says

Young boy dies in trial for Pfizer Duchenne gene therapy

FDA drug safety: Singulair case shows systemic surveillance flaws

explore

entertainment

leisure time

explore